Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Expression of immune-related genes and breast cancer recurrence in women with ductal carcinoma in situ.
Guerini-Rocco E, Bellerba F, Concardi A, Taormina SV, Cammarata G, Fumagalli C, Guerrieri-Gonzaga A, Macis D, Del Fiol Manna E, Balladore E, Cannone M, Veronesi P, Fusco N, Bonanni B, Viale G, Barberis M, Gandini S, Lazzeroni M. Guerini-Rocco E, et al. Among authors: lazzeroni m. Eur J Cancer. 2024 May;203:114063. doi: 10.1016/j.ejca.2024.114063. Epub 2024 Apr 12. Eur J Cancer. 2024. PMID: 38615592 Free article.
Prognostic Value of PCSK9 Levels in Premenopausal Women at Risk of Breast Cancer-Evidence from a 17-Year Follow-Up Study.
Ruscica M, Macchi C, Gandini S, Macis D, Guerrieri-Gonzaga A, Aristarco V, Serrano D, Lazzeroni M, Rizzuto AS, Gaeta A, Corsini A, Gulisano M, Johansson H, Bonanni B. Ruscica M, et al. Among authors: lazzeroni m. Cancers (Basel). 2024 Apr 4;16(7):1411. doi: 10.3390/cancers16071411. Cancers (Basel). 2024. PMID: 38611089 Free PMC article.
Tools to Guide Radiation Oncologists in the Management of DCIS.
Leonardi MC, Zerella MA, Lazzeroni M, Fusco N, Veronesi P, Galimberti VE, Corso G, Dicuonzo S, Rojas DP, Morra A, Gerardi MA, Lorubbio C, Zaffaroni M, Vincini MG, Orecchia R, Jereczek-Fossa BA, Magnoni F. Leonardi MC, et al. Among authors: lazzeroni m. Healthcare (Basel). 2024 Apr 6;12(7):795. doi: 10.3390/healthcare12070795. Healthcare (Basel). 2024. PMID: 38610216 Free PMC article. Review.
Fenretinide in young women at genetic or familial risk of breast cancer: A placebo-controlled biomarker trial.
Aristarco V, Serrano D, Maisonneuve P, Guerrieri-Gonzaga A, Lazzeroni M, Feroce I, Macis D, Cavadini E, Albertazzi E, Jemos C, Omodeo Salè E, Cortesi L, Massarut S, Gulisano M, Daidone MG, Johansson H, Bonanni B. Aristarco V, et al. Among authors: lazzeroni m. Cancer Prev Res (Phila). 2024 Mar 26. doi: 10.1158/1940-6207.CAPR-23-0422. Online ahead of print. Cancer Prev Res (Phila). 2024. PMID: 38530139
Alternative dosing regimen of exemestane in a randomized presurgical trial: the role of obesity in biomarker modulation.
Johansson H, Guerrieri-Gonzaga A, Gandini S, Bertelsen BE, Macis D, Serrano D, Mellgren G, Lazzeroni M, Thomas PS, Crew KD, Kumar NB, Briata IM, Galimberti V, Viale G, Vornik LA, Aristarco V, Buttiron Webber T, Spinaci S, Brown PH, Heckman-Stoddard BM, Szabo E, Bonanni B, DeCensi A. Johansson H, et al. Among authors: lazzeroni m. NPJ Breast Cancer. 2024 Jan 18;10(1):7. doi: 10.1038/s41523-024-00616-8. NPJ Breast Cancer. 2024. PMID: 38238336 Free PMC article.
97 results